Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bruce Rosen who wrote (2364)	2/16/1998 10:29:00 PM
From: Bradpalm1	Read Replies (1) \| Respond to of 7041

Bruce, What amazing sophistry! The scientific arguments against Vasomax have been well articulated here and are, at the very least, as equally compelling as those you apparently support. Zonagen management knew that they had nothing when they originally acquired the rights to phentolamine from Dr. Zorgniotti. It remains to be determined whether their continued promotion of this non-efficacious treatment for ED will be construed as fraudulent. The impending publication of a story regarding Zonagen by a major business publication will be most illuminating. Bradpalm1